Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Rectal Neoplasms 139Esophageal Neoplasms 125Pancreatic Neoplasms 96Esophageal Squamous Cell Carcinoma 84Colorectal Neoplasms 66Adenocarcinoma Of Esophagus 53Stomach Neoplasms 40Carcinoma, Hepatocellular 40Colonic Neoplasms 19Anus Neoplasms 18Neoplasms 14Liver Neoplasms 12Cholangiocarcinoma 10Adenocarcinoma 8Carcinoma, Squamous Cell 7Bile Duct Neoplasms 7Anal Canal Carcinoma 7Head and Neck Neoplasms 6Breast Neoplasms 6Brain Neoplasms 6Prostatic Neoplasms 5Neoplasm Metastasis 5Melanoma 5Lung Neoplasms 5Gastrointestinal Neoplasms 5Gallbladder Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Sarcoma 4Vulvar Neoplasms 3

Interventions

Celecoxib 2Capecitabine 2tegafur-gimeracil-oteracil 1S 1 (combination) 1Radiotherapy 1Pyridoxine 1Pharmacokinetics 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hand-Foot Syndrome × Radiotherapy × Gastrointestinal × Clear all
NCT00305643 2015-12-24

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

M.D. Anderson Cancer Center

Phase 3 Terminated
11 enrolled 7 charts
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pain, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡